Form 483

Camellix, LLC Form 483, 2017-01-17

FDA issued a Form 483 to Camellix, LLC on 2017-01-17 with 15 public-safe observations.

483· Form 483 issuedHuman Drugs15 observations

Camellix, LLC · Evans, United States · Issued January 17, 2017

Overview

  • 15 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

17 Jan 2017
21 CFR 111.16

Written procedures - cleaning

Cited by Christine M Oleary

17 Jan 2017
21 CFR 111.16

Written procedures - cleaning

Cited by Christine M Oleary

17 Jan 2017
21 CFR 111.16

Written procedures - cleaning

Cited by Christine M Oleary

17 Jan 2017
21 CFR 111.465(b)

Retain reserve samples - 1 year, 2 years

Cited by Christine M Oleary

17 Jan 2017
21 CFR 111.465(b)

Retain reserve samples - 1 year, 2 years

Cited by Christine M Oleary

Inspected site

CLCamellix, LLCEvans, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.16Cited across public-safe Form 483 observations3x
21 CFR 111.465(b)Cited across public-safe Form 483 observations3x
21 CFR 111.475(b)(1)Cited across public-safe Form 483 observations3x
21 CFR 111.503Cited across public-safe Form 483 observations3x
21 CFR 111.65Cited across public-safe Form 483 observations3x

Full 483 report

Get the verbatim text of all 15 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere